Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial
On January 8, 2024, the latest research findings from Professor Jiang Zefei's team at the Chinese People's Liberation Army General Hospital were published in the top-tier international journal, Nature Medicine…